Return to Publications
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.

Return to Publications  |  Return to CINJ Home
The Cancer Institute of New Jersey's Cancer Connection, February 2012

Your link to the latest news on research, treatment, prevention and education from the state's only

National Cancer Institute-designated Comprehensive Cancer Center



Arthritis and Cholesterol Drugs Well Tolerated in Prostate Cancer Treatment


Mark Stein, MD

Research from The Cancer Institute of New Jersey (CINJ) on the FDA-approved drugs Celebrex® and Lipitor® - used respectively for arthritis pain and lowering cholesterol - shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented during the 2012 Genitourinary Cancers Symposium, which begins Thursday in San Francisco.Read more

Grant Supports Breast Cancer Surgeon Training at CINJ


breast surgeon training program

Receiving a boost to support its Breast Surgery Fellowship Program, The Cancer Institute of New Jersey has been awarded a $75,000 grant from The Breast Cancer Alliance for academic year 2012-2013. CINJ's one-year fellowship provides surgeons who have completed their general surgery residency with advanced training and experience that prepares them to provide state-of-the-art care specifically for patients with breast disease. The grant will support the work of CINJ's newest breast surgical fellow as of July.Read more

Local Cyclists Pedal to a Record Breaking $200,000 for the Fight
Against Cancer


Scott Glickman

To mark its seventh year, the Century for the Cure bike ride continues to break records, surpassing previous years' efforts and raising $200,000 to directly benefit The Cancer Institute of New Jersey. A check presentation was recently held to recognize the efforts of ride founder and cancer survivor Scott Glickman and more than 135 cyclists and 100 volunteers who participated in the event, which supports cancer research and treatment at CINJ.Read more

RWJMS logo    CINJ logo        NCI logo 

CINJ Office of Communications  ·  195 Little Albany Street  ·  New Brunswick, NJ  ·  732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List